Electromedical Products International Acquires Pulvinar Neuro

Quantum Surgical Acquires NeuWave Medical

February 27, 2026

Medical Devices

Quantum Surgical has acquired NeuWave Medical and combined both businesses under a newly created parent, Precision IO Group Inc., to expand a robotic-assisted tumor ablation platform. The deal is supported by investment from Ally Bridge Group and aims to integrate Quantum Surgical's Epione robotic system with NeuWave's microwave ablation technology to broaden access to minimally invasive interventional oncology care.

Boston Scientific Acquires Valencia Technologies

January 12, 2026

Medical Devices

On January 12, 2026, Boston Scientific acquired Valencia Technologies, the developer of the eCoin System — a coin-sized subcutaneous neuromodulation device for hypertension. The acquisition expands Boston Scientific's neuromodulation and cardiovascular device portfolio by adding a novel, minimally invasive therapy and provides Valencia access to Boston Scientific's regulatory, distribution, and commercialization resources.

Nihon Kohden Acquires 71.4% Stake in Ad‑Tech from ARCHIMED

November 26, 2024

Medical Devices

Nihon Kohden has acquired a 71.4% stake in NeuroAdvanced Corp., the parent of Ad‑Tech Medical Instrument Corporation, from ARCHIMED’s MED II fund, with ARCHIMED retaining a 28.6% minority stake and entering a joint venture with Nihon Kohden. The deal brings together Nihon Kohden’s EEG and monitoring platform with Ad‑Tech’s intracranial neuroelectrodes to strengthen epilepsy diagnostics and expand Ad‑Tech’s global reach across North America, Europe and Asia.

Anumana Acquires NeuTrace to Build Electrophysiology AI Platform

November 7, 2022

Medical Devices

Anumana, an AI-driven health technology company and portfolio company of nference and Mayo Clinic Platform, has acquired NeuTrace and its EP Data Biome platform along with a pipeline of AI-enabled electrophysiology (EP) applications. nference also obtained rights to the Data Biome platform for non-cardiovascular uses, positioning Anumana to expand its in‑procedure AI capabilities and product development across cardiac electrophysiology.

Boston Scientific Acquires Axonics, Inc.

November 15, 2024

Medical Devices

Boston Scientific Corporation agreed to and completed the acquisition of Axonics, Inc., a publicly traded medical technology company focused on sacral neuromodulation and urology devices, for $71 per share (approximately $3.7 billion equity value). The deal expands Boston Scientific’s urology portfolio by adding Axonics’ SNM therapy products and related technologies, expected to be accretive to its Urology business over time.

Pulsar International Acquires Controlling Stake in Navee Technology, Launches Pulsar Türkiye

January 19, 2026

Telecommunications

Pulsar International has acquired a controlling interest in Istanbul-based Navee Technology and established a new operating entity, Pulsar Türkiye. The deal pairs Pulsar's global managed satellite connectivity platform with Navee's local maritime installation, service, and marine electronics capabilities to expand Pulsar's commercial maritime footprint in Türkiye, the Eastern Mediterranean, and the Black Sea.